Danese, E <br/><br/>
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Dec 2012 
 - 746-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2012.184  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Algorithms<br/>Alleles<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Cohort Studies<br/>Coumarins--administration & dosage<br/>Cross-Sectional Studies<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 Enzyme System--genetics<br/>Cytochrome P450 Family 4<br/>Ethnicity<br/>Humans<br/>International Normalized Ratio<br/>Middle Aged<br/>Mixed Function Oxygenases--genetics<br/>Polymorphism, Genetic--genetics<br/>Publication Bias<br/>Sex Factors<br/>Vitamin K Epoxide Reductases